Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 111,607 | 290,281 | 160,079 | 145,537 | 133,367 |
| Cost of Goods | 2,578 | 3,301 | 3,086 | 3,012 | 2,548 |
| Gross Profit | 109,029 | 286,980 | 156,993 | 142,525 | 130,819 |
| Operating Expenses | 201,578 | 309,945 | 193,616 | 194,291 | 192,494 |
| Operating Income | -91,971 | -22,664 | -36,537 | -51,754 | -61,127 |
| Interest Expense | 2,414 | 2,434 | 2,428 | 2,441 | 2,207 |
| Other Income | 4,646 | 10,526 | 7,415 | 18,719 | 10,380 |
| Pre-tax Income | -89,739 | -14,572 | -31,550 | -35,476 | -52,954 |
| Income Tax | 130 | 341,115 | 5,064 | 2,084 | -3,072 |
| Net Income Continuous | -89,869 | -355,687 | -36,614 | -37,560 | -49,882 |
| Minority Interests | N/A | -1,155 | -12,147 | -11,924 | -10,254 |
| Net Income | $-89,869 | $-354,532 | $-24,467 | $-25,636 | $-39,628 |
| EPS Basic Total Ops | -0.64 | -2.54 | -0.18 | -0.18 | -0.28 |
| EPS Basic Continuous Ops | -0.64 | -2.55 | -0.26 | -0.27 | -0.36 |
| EPS Diluted Total Ops | -0.64 | -2.54 | -0.18 | -0.18 | -0.28 |
| EPS Diluted Continuous Ops | -0.64 | -2.55 | -0.26 | -0.27 | -0.36 |
| EBITDA(a) | $-82,233 | $-13,523 | $-27,254 | $-44,063 | $-55,306 |